Dr. Masternak is the Head of Biology at Novimmune. Since joining Novimmune in 2002, he was involved in monoclonal antibody development in the field of inflammation and autoimmunity. He currently oversees immuno-oncology bispecific antibody discovery. Prior to Novimmune, Dr. Masternak worked as a postdoctoral fellow in at the Geneva Medical School, conducting research on the mechanisms of transcriptional regulation of MHC class II gene expression. He received his Ph.D. in virology and molecular biology from the University of Lausanne.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October